Prognostic Indicators as Provided by the EPIC ClearView
Public ClinicalTrials.gov record NCT01476995. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with known diagnoses identified by medical doctors. Specifically, the investigators hypothesize that the organ system involving any of a series of known active diagnoses will be identified in the EPIC ClearView Response Scale report with the intention of providing potential triage capabilities.
Study identification
- NCT ID
- NCT01476995
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 353 participants
Conditions and interventions
Conditions
- Coronary Artery Disease
- Congestive Heart Failure
- Valvular Heart Disease
- Atrial Fibrillation
- Hypertension
- Pyelonephritis
- Acute Renal Failure
- Renal Failure
- Viral Hepatitis
- Alcoholic Hepatitis
- Steatohepatitis
- Cirrhosis
- Asthma
- COPD
- Bronchitis
- Emphysema
- Pneumonia
- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis
- Diverticulitis
- Peptic Ulcer Disease
- Irritable Bowel Syndrome
- Cholecystitis
- Pancreatitis
- Malabsorption Disorders
- Celiac Sprue
- Diabetes
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Jun 2011 (Actual)
- Completion
- Jun 2011 (Actual)
- Last update posted
- Nov 22, 2011
2010 – 2011
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Greater Baltimore Medical Cente | Baltimore | Maryland | 21204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01476995, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01476995 live on ClinicalTrials.gov.